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Abstract 
Circulating levels of C-type 
natriuretic peptides in sheep exposed 
 to a hypobaric atmosphere. 
 
by 
Anita Ferris 
 
Non-pregnant and twin  bearing maternal ewes (n  =  4) of  mixed age were  gradualy introduced to a 
hypobaric atmosphere of 10-11% oxygen saturation. Plasma concentrations of both C-type natriuretic 
peptide (CNP) and its amino terminal form (NTproCNP) are elevated during pregnancy in sheep and 
humans.  However, there  was  no effect  of temporary  hypoxia  on circulating concentrations  of these 
peptides in the pregnant or non-pregnant ewes studied here. This finding shows that a gradual exposure 
to a profoundly hypobaric atmosphere of short duration, does not alter secretion of CNP peptides in the 
circulation of sheep. 
. 
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Chapter 1 
Introduction 
Natriuretic peptides (NP), atrial natriuretic peptide (ANP) and brain natriuretic peptide (BNP) have 
previously been characterised as factors inducing natriuresis, and are commonly up-regulated in 
cardiac tissues (Barr et al. 1996). A third member of the NP family has also been uncovered, C-type 
natriuretic peptide (CNP) is unlike its alternative counterparts in both structure and function. Its 
primary roles appear to  be involved in  maintenance  of  vasculature, and  post-natal  bone 
development, although a role in reproduction and pregnancy has recently been suggested (Walther 
& Stepan 2004; McNeil et al. 2009). C-type Natriuretic Peptide and its amino terminal precursor 
(NTproCNP)  have recently  been  discovered as circulating at  greater concentrations in  pregnant 
compared to non-pregnant ewes, and are further accelerated by increasing fetal number; such that 
levels in ewes carrying twins exceed that  of those carrying a single lamb (Pricket et  al. 2007; 
McNeil et  al. 2009).  Moreover, the exact  purpose that elevated  peptide levels have in the 
maintenance of pregnancy is yet to be elucidated.  
Compared to ANP and BNP, CNP is expressed in low levels within the majority of body tissues. 
However, there are a few areas where secretion is enhanced, such as cerebrospinal fluid and the 
central nervous system (Togashi et al. 1992; Kaneko et al. 1993; Wilson et al. 2015), as wel as 
tissues  of the  myocardium  of individuals suffering cardiac  disease,  blood  vessel epithelia, and 
tissues of the placenta (McNeil et al. 2011). CNP has also found to be a regulator of blood pressure 
which  has led to the theory that it is  promoted  by factors inducing stress such as  nutritional 
restriction (Chun et al. 1997; Pricket et al. 2009). This subsequently suggests a communicative role 
of the peptide between maternal nutrient supply and fetal demands. In the present study we aim to 
identify if  oxygen  deprivation  of short duration  may evoke a similar augmentation  of  maternal 
circulating CNP forms, in order to maintain fetal requirements. This presupposes that a hypobaric 
atmosphere wil generate mild hypoxemia in the placental circulation and that this wil be a direct 
stimulus to secretion of CNP from trophoblast cels. 
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Chapter	  2	  
Literature	  Review	  
2.1	  Introduction 
Unlike the cardiac  hormones  ANP and  BNP, CNP is secreted largely in an autocrine/paracrine 
manner as a neuropeptide (Kojima et al. 1990). CNP is present at very low plasma concentrations 
however it is strongly expressed in a number of somatic tissues, including cerebrospinal fluid (CSF) 
(Togashi et  al. 1992;  Kaneko et  al. 1993; Wilson et  al.  2015),  brain tissues such as the 
hypothalamus, and is increased in  maternal  plasma during  pregnancy (McNeil et  al.  2009). 
Moreover the rise in plasma concentration is proportional to the number of fetuses the mother is 
carrying (Pricket et al. 2007; McNeil et al. 2009). The relation between CNP and pregnancy is 
very unique for NPs, as plasma levels of ANP and BNP are not affected during pregnancy (Barr et 
al. 1996; McNeil et al. 2010). In addition, ruminants alone undergo a unique rise in both maternal 
plasma CNP and NTproCNP levels, in response to elevated placental growth (Pricket et al. 2007; 
McNeil et al. 2009). Although the exact reason for this has yet to be recognized, CNP like ANP is 
involved with the renin angiotensin system (Davidson et al. 1996), thus augmented levels may be a 
consequence of its regulation of blood flow across the utero-ovarian vein 
 
Although there is substantial evidence to identify CNP as an important hormonal participant in the 
pregnancy of most species, its physiological role and relevance to the fetus has yet to be iluminated. 
Pricket (2007) have determined that  nutritional restriction (NR) in  pregnant ewes incites an 
increase in circulatory concentrations of CNP. Because CNP appears to play a functional role in 
meeting  maternal  nutrient supply to fetal  nutrient  demand, the aim  of the current study is to 
determine if exposure of pregnant ewes to a hypobaric atmosphere, may induce secretion of CNP 
or NTproCNP in the the maternal ewe. 
 
2.2	  CNP Structure and Function 
The molecular structure of CNP is much the same as other members of the NP family, omiting the 
absence  of a  C terminal tail,  which has subsequently been  used to explain a lack  of atrial and 
natriuretic capacity (Barr et al. 1996; Poter & Hunter 2001). The Open Reading Frame (ORF) of 
the rat precursor for CNP consists of 126 amino acid residues with the initial 23 residues believed 
to translate a signaling peptide (Melaiu et al. 2012). Analysis of pre hormone products identified 
that while the 22 residue form (CNP 22) was identical to porcine and rat versions, the 53 residue 
form (CNP 53) differed by two amino acid substitutions (Tawaragi et al. 1991; Ogawa et. al. 1992; 
1994; Huang et al. 1996; Melaiu et al. 2012). 
3	  
	  
Cis-regulatory elements adjacent to the TATAA sequence, such as the GGGCGG sequence and an 
inverted Y box (CCAAT) have also been found as unique to CNP which is quite likely the basis for 
its functional variation from other NPs  (Tawaragi et al. 1991; Ogawa et al. 1992; Ogawa et al. 
1994). The amino terminal precursor of CNP 53 and 22, NTproCNP is of greater stability than CNP, 
and therefore is often used as a more accurate method of determining peptide levels (Schouten et 
al. 2010). 
2.2.1	  Regulation of CNP 
Al natriuretic peptides have been associated with either one of two receptors – NPR-A or NPR-B. 
An additional clearance receptor corresponding with the degradation of natriuretic peptides through 
celular internalization, has been identified as NPR-C (Barr et al. 1996; Poter & Hunter 2001). The 
receptors for NPs are signal transducing guanylyl cyclases, that catalyse the synthesis  of cyclic 
guanosine  monophosphate (cGMP) - an intracelular  messenger, to initiate the phospholipase  C 
pathway (Fowkes and McArdle 2000: Poter et al. 2001: Abbey et al. 2002). NPR-A has been linked 
as the preferential receptor for ANP folowed by BNP and CNP. In converse CNP has been found 
to selectively bind with NPR-B folowed by BNP and ANP in preferential order (Abbey et al. 2002; 
Poter et al. 2006). The mRNA of NPR-B has been found in a number of tissues including the lung, 
brain, adrenal gland, kidney, uterus and ovary tissue, although concentrations appear greatest within 
the central nervous system (Kojima et al. 1990) and cerebrospinal fluid (Wilson et al. 2011). NPR-
B is the most prevalent NP receptor in  neuronal regions, including the adrenal medula, pituitary 
gland, and cerebelum (Wilcox et al. 1991; Chrisman et al. 1993; Nagase et al. 1997). 
 
The overal method by which NP receptors are activated is believed to be a two stage process. NP 
binding to an extracelular  domain aids active binding  of  ATP to energise the  kinase  homology 
domain so that consolidation of catalytic domains forms the active site (Poter et al. 2006). As a 
consequence to  ATP  dependency, kinase  domains are regulated through alteration  of 
phosphorylation state (Poter et al. 1998). While activation of the peptide receptors may occur in 
this  manner they  may also  be inhibited  by  hormones  or  growth factors  which contribute to 
vasoconstriction, such as angiotensin II, arginine vasopressin (AVP) and endothelin (Suga et al. 
1992; Poter et al. 2006). CNP and its receptor, NPR-B, have been identified as vasorelaxors, which 
catalyse activation of type 1 cGMP-dependant protein kinase in smooth muscle (Abbey et al. 2002). 
Vasoconstriction results when the likes  of angiotensin II and endothelin,  bind to serpentine 
receptors; that permeate the membrane bilayer seven times, induce a conformational change which 
signals intercelular induction of the phospholipase C-β pathway. More specificaly this enables the 
transition of phosphatidyl inositol triphosphate (IP3) to diacylglycerol - a direct activator of protein 
kinase C (Poter et al. 2006). Conformation of the role of CNP as a regulator of vascular tone was 
achieved by inhibition of angiotensin-I but not angiotensin-II which, suggests it is responsible for 
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suppression of the angiotensin converting enzyme (ACE) for inducing vasodilation (Davidson et 
al. 1996). Inhibition through the inositol triphosphate (IP3) arm has also  been identified by a 
reduction  of CNP-dependant cGMP intracelular concentrations through exposure  of smooth 
muscle cels to AVP (Abbey et al. 2002). This was found to be directly associated with the IP3 
pathway due to the rapid increase  of  intracelular calcium concentrations,  which ultimately 
desensitized the NPR-B receptor to its substrate CNP. A similar mechanism has been suggested 
where augmentation  of endothelial  CNP is  marked  by  AVP and  12-O-tetradecanoyl-phorbol  13 
acetate (TPA),  which further extrapolates that activation  of  phospholipase C mediates CNP 
secretion (Suga et  al.  1992).  However, further analysis is required to elucidate the specific 
molecular  mechanisms responsible for the  production  of  CNP and its receptor  NPR-B and the 
various components involved with regulation.  
 
The nature by which CNP is released is an additional differentiating factor from its NP counterparts. 
ANP and  BNP are secreted and stored in  granules  of atrial tissue and  ventricular  myocytes 
respectively (Arjamaa et  al.  2011). As a result  of  natriuretic  peptide stimulus there can  be an 
immediate surge  of the  product into the circulation. In comparison  CNP is reliant  upon factors 
which regulate its transcription and cannot be secreted in large quantities  (Seliti et al. 2011). An 
interesting discovery is that of nitrous oxide (NO), which appears to have a similar function to CNP 
within vasculature (Seliti et al. 2011). NO has been associated with CNP through its affiliation 
with guanylyl cyclase containing (GC-B) receptor (or NPR-B) to release cGMP, to transduce 
protein kinase C (Chun et al. 1997; Levin et al. 1998; Hou et al. 2003). Pronounced elevations in 
NO have also been correlated to an increased uterine blood flow during pregnancy (Weiner and 
Thompson 1997). This leads to the speculation that CNP and NO are potentialy interlinked in terms 
of regulation and function. 
2.2.2	  Glucocorticoids/sheer stress/nutritional restriction 
Regulation  of  CNP appears to  be associated  with components  of stress including  behavioural 
activity, compromised immune systems, and nutritional deficits.  Fasting of pregnant ewes 120 days 
gestation, for three  days indicated selective  up-regulation  of  plasma  CNP, contrastingly caloric 
loading (200% maintenance) had no effect on circulating forms of the peptide (McNeil et al. 2012). 
Short term nutritional restriction (NR) when the fetus is accelerating in growth rate, resulted in a 
reversible increase  of  both  peripheral and  utero-plasma concentration, this was correlated  with 
reduced placental weight and fetal CNP levels. Long term NR (50% of maintenance requirements) 
in pregnant ewes from 30 days gestation, documented elevated profiles of CNP forms from 40 days 
gestation (Madhaven et al. 2015). Compared to those fed a standard diet, CNP levels of the NR 
ewes  were of a  greater concentration.  Proliferation  of  peptides  were strongly connected with a 
sudden advancement in placental growth, while liter size became significant to CNP accumulations 
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around 60 days gestation (Madhaven et al. 2015). Thus implying a relationship between increased 
nutrient requirement  of the fetus and elevated fetal  CNP forms. It  has also  become evident 
circulating levels of CNP are reduced in NR non-pregnant ewes, which contrasts to the revelation 
that NTproCNP levels are unaffected (Pricket et al. 2010b). Thus, as CNP degradation is enhanced 
in non-pregnant  NR ewes, there  may  be a variability in function of the  peptide associated  with 
pregnancy status. Physiologically, mammalian response to a stressful stimulus (such as  NR) is 
ultimately the  dilation  of  blood  vessels to regulate blood  pressure heart rate and  metabolism. 
Therefore, up-regulation of CNP is quite likely a consequence of the peptides paracrine control over 
vasodilation (Chun et al. 1997). Mean plasma levels of CNP in the utero-ovarian vein were 3-4 
fold higher than maternal atrial levels (Pricket et al. 2007). The rise of CNP in response to reduced 
nutrition in  pregnant ewes may  be an adaptive strategy to maximise  nutrients available to the 
growing fetus. 
2.2.3	  Role of elevated CNP throughout pregnancy 
A substantial rise in maternal plasma CNP concentrations during both human and ovine pregnancy 
(Pricket et al. 2007; McNeil et al. 2009), strongly indicates a functional role for CNP within the 
reproductive axis. This is supported by the discovery that oestradiol within the uterus may mediate 
the expression of CNP as wel as luteinizing hormone (LH) and gonadotrophin releasing hormone 
(GnRH) (McNeil et al. 2011). Discovery of CNP up-regulation in the hypothalamus, particularly 
in the areas  of the arcuate  nucleus (ARC) and  paraventricular  nucleus (PVN),  also implicate a 
neuroendocrine capacity within reproductive endocrinology (Fowkes et al. 2000). A longitudinal 
study of CNP forms during ovine pregnancy identified circulatory concentrations averaged 0.98 
pmol/L and 27.2 pmol/L (CNP and NTproCNP respectively) one week prior to conception rising to 
a maximum of 31 ± 5 and 260 ± 16 pmol/L by day 120. This was folowed by a sudden decline of 
CNP and NTproCNP by 36 and 71% respectively around one week prior to parturition (McNeil et 
al. 2009). In addition both forms of CNP have been found to increase in concentration, in proportion 
to the number of fetuses by days 100 and 135 (McNeil et al. 2011). Authors identified a linear 
increase in circulatory forms of CNP for ewes carrying either single, twins, or triplets. This was 
quantified as an  11-20 fold increase in  plasma  CNP concentration in triplet compared to  non-
pregnant ewes (Wilson et al. 2015). Moreover, analysis of cotyledonary tissues has located a rise 
in CNP concentrations between days 30 and 100 coinciding the spike in maternal concentration 
folowed  by a reduction at this location as  wel as in the  maternal circulation just  prior to term 
(McNeil et al. 2011). Such results imply CNP is sourced primarily from the trophoblast binucleate 
cel (BNC) in cotyledon tissue, with authors also atesting that maternal circulating concentrations 
are regulated independently from fetal concentrations. Thus CNP is likely to be a paracrine mediator 
between the maternal and fetal circulations, predominantly by maintaining blood flow to uterine 
tissues during gestation. 
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The quantity and quality of ruminant placental atachments are highly responsive to increasing liter 
size. This enables the transportation of nutrients and waste products between maternal and fetal 
circulations to be maximised. Caruncles on the maternal side, which form cotyledon atachments at 
pregnancy, are unique only to ruminant species, which may explain the marked rise in circulating 
CNP forms when growth of the placenta is at its greatest (Pricket et al. 2007; McNeill et al. 2009; 
Madhavan et  al. 2015). Further scrutiny  of  utero-placental tissues revealed that  CNP and 
NTproCNP levels, were most abundant in ovine fetal cotyledon tissues (McNeill et al. 2011). A 
significant elevation was detected in cotyledon samples 30 days after conception, and progressed 
consistently  until  day  135 (of a  150  day  gestation), where upon they sharply  declined prior to 
parturition (McNeill et al. 2011). Subsequent to this finding, authors found that both forms of CNP 
within pregnant ovine uteri are reportedly low, and equivalent to levels obtained from non-pregnant 
ewes.  Moreover, in absence  of a concentration  gradient across the  umbilical artery there is  no 
evidence to suggest a source of CNP secretion outside of the placenta (McNeil et al. 2011). McNeil 
(2010) showed a progressive reduction of both  peptides in fetal circulations, which corresponds to 
the increase found in the maternal circulation. In slight contrast, recent analysis into the effects of 
nutrient restriction identified elevation  of maternal peptide forms, however fetal  plasma 
concentrations appeared  unaffected  by a reduced  nutrient supply (Madhaven et  al. 2015). 
Therefore, it is likely that fetal and maternal circulations are independent of one another, which 
simultaneously insinuates an additional function for CNP in the pre and post-natal fetus (Pricket et 
al. 2007; McNeil et al. 2010). Such alternative functions appear to involve the ossification of fetal 
bone growth (Walter and Stepan 2004). Observations revealed, that gene knockout of Nppc, the 
gene encoding CNP, was a direct cause of severe dwarfism in mice (Cusho et al. 2001; Komatsu et 
al. 2002), however there has been litle atention to expressivity of Nppc in larger species. 
2.2.4	  Endothelial and peripheral CNP secretion  
Unlike other natriuretic peptides, CNP is produced in parenchymal cels in the kidneys of rats, as 
supported  by the  presence  of its receptor,  NPR-B (Barr et  al.  1996). Furthermore, authors were 
unable to find an association  of the  peptide  with  diuresis, a  mechanism  which  was  previously 
thought to be the basis of natriuretic peptide function. However in cardiac tissues NPR-B has been 
extracted from the human myocardium, thus implying an involvement of CNP with the regulation 
of smooth  muscle, endothelial tissue, in addition to the  development and  maintenance  of 
cardiovascular health (Seliti et  al.  2011).  While  many studies  have examined factors  which 
differentiate CNP as a natriuretic peptide, there is some indication that the molecule may be up-
regulated in endothelial cels in response to increased ANP levels, by as much as 20-fold (Nazario 
et  al.  1995).  While  many investigations  on cardiac  disease and  CNP expression have  been 
undertaken, the majority have deduced, that despite the involvement of CNP in reducing cardiac 
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fibrosis (Soek et al. 2005), myocardial CNP expression is not as great a contributor as that of ANP 
or BNP to cardiac disease (Seliti et al. 2011). Transforming growth factor-β (TGFβ) has also been 
reported to augment secretion of CNP from cultured endothelial cel by as much as 30-60 fold, 2230 
± 180 compared with a control concentration of 17.2 ± 1.2 fmol/106 cels, (Suga et al. 1992). In the 
same study, thrombin and AVP were shown to advance CNP concentrations although not to the 
same degree as TGFβ. It is prevalent that CNP secretion from endothelial cels is stimulated by a 
number of vasoactive materials, however an accurate description of CNP in vascular tissue is not 
yet available. There is strong evidence that CNP is involved along with ANP and BNP in a system 
that is antagonistic towards the renin angiotensin system (Suga et al. 1992). These authors theorised 
that while CNP could induce relaxation of vascular smooth muscle cel in a paracrine nature it could 
also maintain endothelial proliferation and/or function in an autocrine manner, as indicated by the 
stimulation of CNP secretion by TGFβ. While there are a number of components that influence the 
level  of  CNP secretion it is likely that the  majority  of components are inter-linked with renin-
angiotensin system. 
2.3	  The effect of hypobaric environment on circulating natriuretic peptide 
levels 
Preliminary studies evaluating the physiological effect of hypoxic environments on expression of 
natriuretic peptides have revealed mixed results. Analysis of ANP in male rats suggested that NP 
may  be linked  with the renin-angiotensin axis  which is activated  by lowered  oxy-haemoglobin 
concentration, although the plasma ANP response failed to reach significance (Winter et al. 1988). 
However, a chronic response involving hypoxic exposure of up to 7 days has achieved an increase 
in plasma ANP concentration of up to 60% (27.2 ± 2, 43 ± 3control and treatment respectively) 
(Winter et al. 1988). The basis that chronic subjection to hypoxia has on natriuretic peptide secretion 
is associated with the manner in which ANP and BNP, but not CNP, are stored as secretory granules 
–in atrial tissue  and in  ventricular  myocytes (ANP and  BNP respectively). Investigation  of the 
granule density supplying immediate ANP secretions folowing a seven days exposure to hypoxia 
showed a significant reduction, while elevated levels of ANP in plasma suggest transcription rate 
was increased to meet demand (Winter et al. 1988). A smal average elevation of 34 ± 18% was 
detected in circulating amino-terminal BNP in 50% of subjects acutely exposed to hypoxic air of 
11%  oxygen content (Heinonen et  al. 1998). Because this  was  not  observed in  more  of the 
participants, and there is such a  great  degree  of  deviation, there is litle  understanding  of the 
connection between NP and hypoxia at this time; although it may be that long term subjection to a 
low oxygen environment could regulate the NP system. 
 
Mechanisms associated  with adaption to anoxia ultimately result in an increased efficiency  of 
oxygen transport to cels via a rise in haemoglobin concentration, and an increase in blood pressure 
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aided by elevated heart rate. Mechanisms that mitigate any lowered supply of inspired oxygen are 
controled  by transcriptional activators  known as hypoxia inducible factors (HIF-1α). Increased 
transcriptional activity of HIF-1α appear to be an initial response that instigate the activation of a 
number  of additional transcripts involved  with  oxidative stress. These include, vascular tone 
controling endothelin nitric oxide synthase and adrenomedulin, as wel as a number of glycolysis 
participating enzymes such as  glyceraldehyde-3-phosphate synthase (Semenza  2001). Hypoxia 
inducible transcriptional activators may depress metabolism by the tricarboxylic acid cycle (TCA) 
directly through transactivation  of the  pyruvate  dehydrogenase  kinase  1  gene, thus converting 
production of ATP to the glycolysis pathway (Kim et al. 2006). Analysis of the location of HIF-
1α have been associated with sites encoding members of the natriuretic peptide family. Chun (2003) 
reported that the transcription  of  ANP  mRNA is  preceded  by  HIF-1α and  was concomitantly 
activated by factors inducing HIF-1α such as CoCl. Moreover the  ANP  promoter in ventricular 
myocytes was found to be catalysed by an HIF-1α (Zenteno-Savin et al. 1988; Naka et al. 2007), 
which is feasible given the functional association ANP has with chronic hypoxia. 
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Chapter 3 
Methods and Materials 
3.1.1	  Animals 
Eight mixed-age, fuly fleeced  Coopworth-cross ewes – 4 carrying twins,  4  non-pregnant – and 
weighing between 59 and 85 kg were used in this study, approved by the Lincoln University Animal 
Ethics  Commitee.  Pregnancy status (non-pregnant, or pregnant-twin lambs present) was 
determined between 95 and 110 days of gestation by trans-abdominal ultrasonography performed 
by a commercial scanning operator. The sheep selected were part of a larger mob grazing pasture 
that was predominantly perennial ryegrass and white clover. All ewes were brought indoors and 
placed into individual pens 2 days preceding the trial, so that they could transition to a diet that 
consisted of: 1.2 kg lucerne pelets (9.5 MJME/ kgDM, 18.22% CP, 20-25% fibre) and 0.75 kg of 
lucerne chaff daily with water available ad libitum. Prior to its run in the hypobaric tent, each ewe 
had food  withheld  overnight. To identify the effect  of  hypoxia  on the  pregnant ewes a  pulse 
oximeter was atached to the ear for the entire run, to measure haemoglobin (Hb) saturation and 
heart rate. Readings of the pulse oximeter and oxygen concentration within the tent were recorded 
every half hour throughout the hypoxia period; in some cases tape was used to secure the device to 
the ear to help maintain its atachment and prevent the ewe from chewing the wires. The maternal 
ewes were estimated between 110 to 132 days of gestation over the period that the examinations 
occurred. Pregnant ewes lambed between 9 and 24 September 2015, with three of them giving birth 
to twins and one having a single lamb. 
3.1.2	  Experimental procedure 
The study comprised four official sessions, 8 ewes were divided into two groups (2 pregnant and 2 
non-pregnant), and were then out into pairs (1 pregnant, 1 non-pregnant). Each group of 4 ewes 
underwent  2 runs so that every  pair  were subjected to  both a session  of  normoxic sea level 
conditions around  770  mmHg, and  hypoxic conditions around  400  mmHg.  Hypoxic ewes were 
placed held in individual sheep crates within a tent, while normoxic counterparts remained in their 
holding pens indoors. From each of the 4 sheep being examined venous blood sample (10 mL) was 
obtained by venepuncture from an external jugular vein whilst the sheep was manualy restrained, 
using evacuated  plastic tubes containing sodium ethylene  diamine tetra acetic acid (B  D 
Vacutainer®, Becton Dickinson and Company, Franklin Lakes, NJ, USA) as anticoagulant and a 
0.9  x  25  mm  needle (Precision GlideTM,  Becton  Dickinson and  Company).  Immediately  on 
withdrawal  of the sample, each tube  was  gently inverted a few times to ensure  dispersal  of the 
anticoagulant then placed on ice. The two hypoxic ewes were held securely in separate steel crates 
(1 x 1 m height and length and 0.5 m wide) within the tent (2 x 2 x 2 m, GO2 Altitude 1999-2012, 
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Biomeditech Australia Pty Ltd, Melbourne, Australia), and were then subjected to air which was 
progressively reduced in oxygen content by use of the hypoxicator system described below. Air 
temperature during the runs varied between 15 and 25°C inside the room where the tent was sited, 
and 10-15 °C within the holding shed where the control (Normoxic) animals were held throughout 
the study period. Figure 1 shows the patern of reduction in O2 concentration in the tent during the 
runs. Runs 1 and 2 took place on consecutive days (21 and 22 July) commencing at 0930 h and 
lasting for 5 h at the end of which al 4 ewes were blood sampled (as above) and the air in the tent 
replaced by normal atmospheric air. Runs 3 and 4 utilised the remaining 4 ewes in the study, the 
protocol was identical to that described for Runs 1 and 2 (above), except both trials were conducted 
in a single day (24 July, Run 3 commencing at 0830 h and Run 4 commencing at 1410 h). A fifth 
and final session  was also  undertaken  with the four  pregnant ewes to  determine if increasing 
duration of hypoxia from 5 hours to 7 would have any effect.  
3.1.3	  CNP peptide assays 
Venepuncture was undertaken on three occasions with each experiment on both normoxic hypoxic 
and  pregnant  non-pregnant ewes,  once  prior to activation  of  hypoxicator (1st sample); again 
immediately folowing termination of the hypoxicator 5 hours later (2nd sample); and again one hour 
later (3rd Sample). Soon after colection  blood samples  were centrifuged at  1000 g in a  bench 
centrifuge for  15  minutes and  plasma  was colected  by aspiration and  placed in  12 x 75 mm 
polycarbonate tubes to  be stored frozen (-20°C).  Plasma samples  were analysed  using 
radioimmunoassay to determine NTproCNP and CNP concentrations as described by Wilson et al. 
(2015). 
3.1.4	  Hypoxicator system for producing hypoxic air  
Hypoxic air  was  generated  by two four  person ‘hypoxicator’ systems (GO2  High  Altitude 
Simulator© 1999-2012, Biomeditech Australia Pty Ltd, Melbourne, Australia) that were designed 
to provide a high altitude simulation environment for training athletes. This used a compressor to 
pressurise atmospheric air and a semi-permeable membrane to separate oxygen from nitrogen. The 
nitrogen-rich air was supplied from two generating systems operating in paralel, to the fuly sealed 
tent containing the 2 ewes. Oxygen composition of the air was measured by a hand held oxygen 
analyser (maxO2+A, Maxtec, Salt Lake City, Utah, USA) which hung inside the tent where it could 
be read through a window throughout the exposure period. 
3.1.5	  Statistical analysis 
The  data were analysed  by  using a  balanced ANOVA (Minitab, Sydney, NSW  2000). More 
specificaly, individual animal difference of CNP and NTproCNP concentrations between 1st and 
11	  
	  
2nd blood samples  were examined to identify the existence  of any statistical relationship  with 
hypoxia, and the correlation this may have had with pregnancy. 
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Chapter 4 
Results  
4.1.1	  Hypoxic Conditions 
The oxygen concentration within the tent containing the Hypoxic ewes decreased steadily during 
the first 4 hours then slowly setled to minimal values (between 10.4 and 11% v/v, or 369 to 394 
mmHg O2) in the final hour of the treatment period (Figure 1). Normoxic sheep experienced normal 
atmospheric conditions throughout the study which averaged  758.5  mmHg  over the trial period 
(Figure 2). Pulse oximeter readings were highly variable within individuals. In every run the pulse 
oximeter  was shaken  off and the  process  of entering the tent to replace the  device immediately 
renewed the atmosphere. The few readings that were obtained confirmed that there was an overal 
decline and increase in Hb saturation, and heart rate respectively, these were immediately corrected 
upon opening of the tent and exposure to normoxic air (Figure 3, Figure A. 1, in Appendix 1) 
 
 
 
 
 
 
 
 
9.0%
11.0%
13.0%
15.0%
17.0%
19.0%
21.0%
07:55
08:38
09:21
10:04
10:48
11:31
12:14
12:57
13:40
14:24
15:07
15:50
16:33
17:16
18:00
Oxy
ge
n	  C
onc
ent
rat
io
n	  %
Time
Session	  5 Session	  4 Session	  3 Session	  2 Session	  1
Figure	  1:	  The	  level	  of	  hypobaric	  atmosphere	  delivered	  to	  hypoxic	  ewes	  within	  the	  tent.	  
The	  time	  frame	  shows	  the	  rate	  of	  declining	  oxygen	  content	  was	  gradual	  for	  
each	  run	  that	  was	  undertaken.	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4.1.2	  Plasma concentrations of CNP forms 
Pregnant sheep had higher (P < 0.001) mean concentrations of CNP and NTproCNP overal than 
non-pregnant sheep (Table 1).  The highest values for CNP and NTproCNP concentrations recorded 
from the study, 111.93 and  3712  pmol/L respectively,  were from pregnant ewes. There  was a 
decline in circulating NTproCNP concentrations of the pregnant  hypoxic  group compared to 
normoxic pregnant counterparts (Table 1 Figure 5). However, there was no effect of the hypobaric 
atmosphere on  CNP peptide concentrations (P = 0.077 and  0.074 for CNP and  NTproCNP 
respectively (Figures 4 &5, Table 1).  
Table	  1:	   The	  variation	   between	   the	   1st	  and	   2nd	  blood	  sample*	  in	  both	  CNP*	  and	   NTproCNP*	  
circulating	   concentrations	  of	  hypoxic/normoxic	   and	   pregnant/non-­‐pregnant	   ewes	  ±	  
S.E.M*.	   Probability	   (P)	  is	   also	   provided	  to	   show	  statistical	   correlation	   between	  
NTproCNP*/CNP*	  levels	  and	  hypoxia.	  
 
* CNP: C-type natriuretic peptide  *NTproCNP: amino terminal C-type natriuretic peptide. * Sample 
number  1  prior to  hypoxia, sample  number  2 immediately folowing termination  of 
hypoxia. * S.E.M: Standard error of the mean. 
 NTproCNP pmol/L CNP pmol/L 
 Pregnant 
Non-
Pregnant 
P 
Pregnant Non-Pregnant 
P 
Hypoxic -420.28 ±65.53 6.65±1.36 0.074 -15.16 ± 1.57 0.145 ± 0.021 0.077 
Normoxic  18.7±71.42 1.25±1.39 2.46 ± 3.62 -0.08 ± 0.054 
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Figure	  2:	  Atmospheric	  total	  pressure	  readings	  recorded	  at	  a	  local	  weather	  recording	  station	  during	  
study	  period	  showing	  the	  values	  for	  each	  run	  of	  the	  study. 
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Figure	  3	  Heart	  rate	  of	  two	  hypoxic	  pregnant	  ewes	  (Heart	  Rate	  1	  and	  Heart	  Rate	  2)	  recorded	  during	  
the	  period	  of	  increasing	  hypoxia	  (decreasing	  oxygen	  %	  of	  the	  air)	  measured	  by	  pulse	  
oximetry	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Figure	  4:	  Circulating	  CNP*	  concentrations	  of	  hypoxic	  and	  normoxic	  pregnant	  and	  non-­‐pregnant	  ewes	  of	  
3	  plasma	  samples;	  sample	  number	  1	  prior	  to	  hypoxia,	  sample	  number	  2	  immediately	  
folowing	  hypoxia,	  and	  sample	  number	  3	  one	  hour	  later 
15	  
	  
 
 
NTproCNP:	  Amino	  terminal	  C-­‐type	  natriuretic	  peptide	   
	  
	  
	  
	  
	  
	  
	  
	  
	  
	  
	  
	  
	  
	  
	  
	  
	  
	  
	  
	  
0
10
20
30
40
50
60
70
1 2 3
NTp
ro
CN
P	  p
mol
/L
Sample	  Number
Non-­‐
pregnant	  
Hypoxic
Non-­‐
pregnant	  
Normoxic
0
500
1000
1500
2000
2500
3000
3500
1 2 3
NTp
ro
CN
P	  p
mol
/L
Sample	  Number
Pregnant	  
Hypoxic
Pregnant	  
Normoxic
Figure	  5:	  NTproCNP*	  concentrations	  of	  hypoxic	  and	  normoxic	  pregnant	  and	  non-­‐pregnant	  ewes	  of	  3	  
plasma	  samples;	  sample	  number	  1	  prior	  to	  hypoxia,	  sample	  number	  2	  immediately	  
folowing	  hypoxia,	  and	  sample	  number	  3,	  one	  hour	  later.	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Chapter 5 
Discussion 
5.1.1	  Efect of hypoxia on CNP and NTproCNP 
There was no relationship between circulating  CNP  or  NTproCNP concentration in  pregnant or 
non-pregnant animals and exposure to a hypobaric environment. NTproCNP levels of the pregnant 
hypoxic ewes appeared to decline by 441 pmol/L on average between the 1st and 2nd blood samples 
(Figure 5,  Table  1). In contrast,  normoxic  pregnant ewes  were found to  have lower average 
circulating concentrations  of  NTproCNP at the same sample time (1st sample) as  hypoxic 
counterparts. This suggests that the trend observed in hypoxic pregnant ewes is not a response to 
anoxia, but is probably a consequence of individual variation observable by the degree of variation 
in the data (Table 1). Previous examination into the effect of oxygen deprivation upon circulating 
forms of NPs (as discussed in section 2.3) indicates a potential relationship (Heinonen et al. 1998; 
Arjamaa et  al. 2011).  However, the  design  of these studies involved only repetitive  periodic 
exposure (1-2 hours) of profound anoxia over the course of several days. In comparison the present 
study achieved below 60% of normal sea level atmospheric conditions for 120 minutes in the 5 hour 
and was increased to 250 minutes in the extended 7 hour run. However subjection to hypoxia for 
an additional 2 hours had no effect on circulating peptide concentration. Although there have been 
no previous investigations  of hypoxia  on  maternal  CNP secretion, it seems evident that the 
atmospheric oxygen saturation achieved within the tent should have been sufficient to induce a short 
term response of CNP forms if one were to occur. 
Both CNP and NTproCNP levels were found to vary from one another at each sampling (Figures 4 
&  5), however there  was  no identifiable trend to accurately  quantify this  disparity. NTproCNP 
levels were compared in pregnant ewes in the morning (0900 h), afternoon (1400 h), and an hour 
later (1500 h), although one trial ran later into the evening (7-8 pm). Because circulating levels of 
both peptides varied widely between individuals (Figure 4 &5), and the distribution of continual 
sampling throughout the day covered only a smal proportion (6-8 hours), statistical significance 
between CNP levels and time of day could not be verified under the current design. 
5.1.2	  Maternal and fetal tolerance to hypoxia 
Examination of Tibetan individuals that have colonised vilages between altitudes of 2500 and 4000 
m (570, 475 mmHg respectively), have unveiled that chronic exposure to hypoxia may be adapted 
through increasing the efficiency of oxygen transport by haemoglobin (Simonson et al. 2010; Beal 
2014). This indicates that while oxygen is vital, a moderate restriction of atmospheric oxygen is 
habitable, if the assault is ongoing. Adaptation to a change in O2 concentrations of short duration 
(seconds-minutes)  may  be an  outcome  of altering  protein concentrations, contrarily chronic 
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exposure represent alterations in synthesis of DNA transcripts (Semenza 2000). This indicates an 
alteration in responses from either chronic or acute stimuli. Regardless, the increased inhalation of 
carbon dioxide (CO2) which lowers pH of plasma would be supposed to have a number of effects 
on placental function. An additional query is the detected elevated heart rate observed by the pulse 
oximeter in ewes that maintained a secure atachment (Figure 3). Studies of apnoea in seals detailing 
a  decreased  heart rate (Zenteno-Savin  &  Castelini  1998), or bradycardia  of  hypoxemic fetuses 
(Giussani et  al. 1993; Jelyman et  al. 2005) would suggest that  heart rate should  decline  with 
decreasing  oxygen supply. The  primary  physiological retaliation to an increased carbon  dioxide 
inhalation is an increased respiratory rate, which is driven by a greater cardiac output so to maximise 
oxygen uptake (Kiely et al. 1996). In converse to the current results, apnoea in humans has been 
found to reduce heart rate by 18 %, however, bradycardia was also induced 19% by hypoxia (Lin 
et al. 1983). While this disagrees with the present study, an evaluation of mild hypoxia (10% O2) 
in dogs has established an increase of 87±15 ml/min/kg to 101±14 ml/min/kg (Adachi et al. 1976). 
Furthermore, hypercapnia in humans also resulted in elevated heart rate, stroke volume, and cardiac 
output folowing inhalation of 7 kPa of CO2 for 30 minutes (Kiely et al. 1996). This recognises the 
significance by which, physiological response can vary through utilisation of different mechanisms 
to induce  oxygen  deprivation, such as apnoea,  hypoxia,  hypoxemia,  or  hypocapnia; due to the 
sensitivity by  which  homeostatic  defensive mechanisms are activated  by elevated CO2 levels. 
Moreover, it is apparent that measurement  of  CO2 levels could  have  been a very useful tool in 
determining the level of hypoxia experienced by the pregnant ewes. Because of the nature of the 
current design, where hypoxia was introduced gradualy, it is questionable whether the stimulus 
was of an acute manner. Gradual introduction to a very low oxygen content may have enabled ewes 
to acclimatise rather than if subjected to a sudden severe reduction of oxygen inhalation.    
It has yet to be fuly elucidated whether exposure of pregnant ewes to hypoxia may elicit a response 
in CNP secretions. Although the fetus exists in a relatively hypoxic state, this oxygen supply is 
generaly thought sufficient (Richardson & Bocking 1998). The unborn neonate may also respond 
to reduced  O2 supply through increasing  production  of fetal  haemoglobin (α2γ2 subunits)  which 
incidentaly, has a greater affinity for oxygen than the mature form (α2β2 subunits); as saturation 
occurs at 21 mmHg and 28 mmHg respectively (Winslow 2007). Metabolism of the ovine fetus 
may be predominantly governed via maternal glucose rather than oxygen supply, as glucose alone 
was found to sustain  up to 50-70% of oxidative  metabolism (Bataglia & Meschia  1978). This 
suggests that in terms of an adaptive response, hypoxia and nutritional restriction appear to evoke 
separate pathways for altering fetal metabolism. 
Catecholamines adrenaline and noradrenaline, as wel as energy substrates glucose and lactate, were 
found to vary in retaliation to an acute one hour exposure of hypoxic air (9% O2 and 3% CO2) every 
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24 hours, over eight days. Fetal plasma glucose levels rose 0.5 µmol/ml in response to hypoxia, in 
fetuses within 130-days  gestation, while exposure from  140+  days equated to a surge  of  1.3 
µmol/ml; conversely maternal glucose levels remained relatively constant to the assault from 118 
days gestation (Jones  1977). This agrees  with an alternative study identifying increased plasma 
glucose concentrations in consequence to temporary hypoxaemia,  glucose  was further was 
accelerated by treatment of dexamethasone (Jelyman et al. 2005). These results demonstrate that 
from ~118 days the fetus has developed a sufficient independence from maternal circulations to 
respond appropriately to diminished oxidative supply. Fetal lactate concentrations have also been 
found to rise progressively from 1.9 to  10.5 µmole/ml,  peak levels  were achieved  10  minutes 
folowing hypoxia termination and returned to base line values up to 24 hours later (Jones 1977). 
Free faty acids (FFA) were found to rise gradually from 95 days to term in sheep, and have been 
theorized as catalysing the increased release  of catecholamines,  particularly adrenaline from 
sympathetic nerve terminals (Jones 1977; Richardson & Bocking 1998). The literature also agree 
that FFAs, and lactate appear to significantly contribute to a non-oxidative metabolism of the fetus 
when  oxygen supply is restricted (Ahlborg et  al. 1974;  Russel et al.  2008). Formation  of 
bradycardia in 125 day ovine fetuses given 9% O2 for an hour, was found to be enacted through the 
muscarinic  pathway, characterized  by a  G-coupled acetylcholine receptor, due to its subsequent 
inhibition  by atropine (Giussani et  al. 1993).  Authors  determined the α-adrenergic  mechanism 
activated  by carotid chemoreceptors of the femoral  vasculature, in addition to the rising 
catecholamine levels, were both pivotal for survival of unborn subjects. It has become evident that 
advancing levels of catecholamines both late in gestation, and up to 30 minutes post parturition, are 
crucial for ensuring adequate energy is available for lamb survival (Van  Duyne et  al. 1960). 
Furthermore, there is some evidence to suggest that CNP may regulate the level of catecholamine 
induced and spontaneous release as 1,  10, and  100  nm CNP were found to significantly reduce 
secretions of neuronal norepinephrine (Vata et al. 1996). Although the present study failed find 
such an association, subjection to an acute  hypoxia results in enduring alterations of  oxidative 
metabolism in the fetus. 
These reports also describe an association of gestational age and hypoxia response of the fetus, for 
example, hypoxic induction of free faty acid release in fetal plasma was only determined significant 
from  130  days  gestation (Jones  1977).  This indicates in the current study that as fetuses  were 
between 110 and 132 days old, they were probably of sufficient age to respond appropriately to an 
anoxic stimulus in terms of growth and metabolic rate. 
Ovine fetuses exposed to acute hypoxia, exhibited a 20% reduction in both hepatic and umbilical 
venous blood flow (Bristow et al. 1983) In addition, hepatic oxygen uptake of the fetus was greatly 
reduced in the right hepatic lobe (45%), and unchanged in the left. A study discerning fetal response 
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to a short (60 minutes) sharp (9% O2) incidence of hypoxia indicated an increase in carotid blood 
flow but not vascular resistance. Further examination into the effects of restricting umbilical blood 
flow revealed that although fetal oxygen delivery was reduced by up to 50%, oxygen consumption 
was sustained through increasing extraction (Richardson & Bocking 1998). However, depletion of 
O2 beyond  50% causes a  higher  gradient  of partial  pressure  oxygen (PO2) which  due to 
transportation by utero-placental diffusion, results in reduced arterial PO2 and hypoxemia of the 
fetus (Richardson & Bocking 1998). Jones (1977) also proposed that alterations of organ blood flow 
may be responsive to varying tissue uptake of metabolites and not only a consequence of glycogen, 
triglyceride and protein degradation. This is confirmed in fetuses exposed to prolonged hypoxemia, 
as consumption of oxygen became proportional to quantity delivered yet blood gas values were 
normalised (Richardson & Bocking 1998). Thus suggesting that processes which expend an excess 
of  oxygen such as  growth and  potentialy  behavioural activity such rapid eye  movement, are 
suspended until an adequate supply returns (Koos et al. 1987; Hooper et al. 1990; Giussani et al. 
1993). Acute exposure to hypoxaemia elicited a transient bradycardia, reduced blood pressure and 
femoral blood flow of the feus that could be rectified by an increase in catecholamine secretion 
without an initial effect on growth rate (Jelyman et al. 2005). It is proposed that bradycardia reduces 
myocardial flow which in turn alows a greater captivation of oxygen by fetal haemoglobin whilst 
minimising oxygen consumption of the cardiac tissues (Fisher et al. 1982). Similar investigation 
into fetal hypoxemia, found that lowering PO2 by just 5 mmHg elevated lactate levels between 15-
22  mg/dL and cortisol concentrations  by  5-9  ng/ml  between  122 and  139  days  gestation  has an 
immediate and profound effect on pre-natal metabolism (Towel et al. 1987). Fetal activity appears 
highly sensitive to maternal PO2 and is capable of adjusting through lowering metabolic rate and 
increasing glucose levels so that function of the vital organs may be maintained. As the fetus is 
capable of independently maintaining oxygen consumption to meet demand at late gestation, there 
may be very litle additional requirements for oxygen supply in pregnant ewes. This may indicate 
that  up-regulation  of  CNP forms in the  pregnant ewes is  not  necessary  when a  mild short term 
hypoxia is induced.  
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Chapter 6 
Conclusion 
Hypoxia elicited  no alterations  of circulatory  CNP  or  NTproCNP concentrations in either twin 
bearing pregnant, or non-pregnant ewes. The degree of hypobaric hypoxia achieved here is believed 
to  have  been sufficient to stimulate a response  were one to  occur. However, it is  possible that 
secretion  of CNP forms  may  be augmented differently  by either acute  or chronic exposure to 
hypoxia; although there is no current literature to support this theory. The fetus appears to be highly 
sensitive to decreasing oxygen supply – increasing non-oxidative metabolism, as wel as glucose 
and catecholamines to reduce oxygen use. Although none of these aspects were measured in the 
current  design, they strongly suggest that  oxygen  deprivation endorses a sudden and  violent 
response  of the fetus to reduce  oxygen consumption. In consequence the late  gestation fetus is 
capable of independently reducing its demand for oxygen from the mother in response to hypoxia. 
In conclusion, NR stimulates CNP release as its ability to dilate blood vessels maximises utero-
ovarian blood flow, comparatively gradual acclimation to hypoxia is dissimilar. The current study 
provides evidence that hypoxia may not induce peptide secretion, in consequence to independent 
fetal regulation of metabolism and oxygen consumption.  
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